【摘要】 目的：分析药品供应保障政策演进逻辑，为完善我国药品供应保障体系提供参考。方法：系统梳理新中国成立至2024年国家层面出台的药品供应保障相关政策文件，并结合政策文件编码揭示政策关键议题，从医保、医疗、医药协同视角分析政策演进逻辑。结果：我国药品供应保障政策整体践行了从“严格控制”到“逐步放松”再到“协同发展”的演进逻辑。药品供应保障必须坚持医疗、医保、医药协同视角下的交互式统筹决策，同时兼顾药品的准公共物品属性和一般商品属性。结论：药品供应保障不是简单的用药问题，更重要的是推动健康保障体系高质量发展和全民健康状况的改善。更多还原

【Abstract】 Objective: To analyze the policy evolution logic of drug supply security, in order to provide references for the improvement of China’s drug supply security policy. Methods:Policy documents related to drug supply security at the national level from the founding of New China to 2024 are systematically summarized. The policy texts are coded to reveal the key issues of the policy,and the logic of policy evolution is analyzed from the perspective of the synergy among health insurance,medical care and pharmaceuticals. Results:China’s drug supply security policy as a whole has practiced the evolutionary logic of “strict control,“gradual relaxation”,“synergistic development”. The guarantee of drug supply must adhere to the interactive and integrated decision-making under the synergistic perspective of medical care, medical insurance and pharmaceuticals, while taking into account the attributes of quasi-public goods and the attributes of commodities in general. Conclusion:The security of drug supply is not simply a matter of medication, while the promotion of the high-quality development of the health security system and the improvement of the health status of the entire population are more important.更多还原